1	¿	¿	Fia	-	-	366-367	169_QUEST_clinical_caseMIR	SENT1	-	-
2	Cuál	cuál	PT0CS000	-	-	367-371	169_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	372-374	169_QUEST_clinical_caseMIR	SENT1	-	-
4	estos	este	DD0MP0	-	-	375-380	169_QUEST_clinical_caseMIR	SENT1	-	-
5	fármacos	fármaco	NCMP000	C0013227	sustancia	381-389	169_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	es	ser	VSIP3S0	-	-	390-392	169_QUEST_clinical_caseMIR	SENT1	-	-
7	eficaz	eficaz	AQ0CS0	C1704419	calificador	393-399	169_QUEST_clinical_caseMIR	SENT1	-	-
8	para	para	SPS00	C0521125	calificador	400-404	169_QUEST_clinical_caseMIR	SENT1	-	-
9	aumentar	aumentar	VMN0000	-	-	405-413	169_QUEST_clinical_caseMIR	SENT1	-	-
10	la	el	DA0FS0	-	-	414-416	169_QUEST_clinical_caseMIR	SENT1	-	-
11	masa	masa	NCFS000	C1306372#C0577559	calificador#hallazgo#anomalía_morfológica	417-421	169_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
12	ósea	óseo	AQ0FS0	C0443157	calificador	422-426	169_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
13	y	y	CC	C1706368	calificador	427-428	169_QUEST_clinical_caseMIR	SENT1	-	-
14	disminuir	disminuir	VMN0000	-	-	429-438	169_QUEST_clinical_caseMIR	SENT1	-	-
15	el	el	DA0MS0	-	-	439-441	169_QUEST_clinical_caseMIR	SENT1	-	-
16	riesgo	riesgo	NCMS000	C0035647_1	calificador_1	442-448	169_QUEST_clinical_caseMIR	SENT1	-	-
17	de	de	SPS00	C0035647_2	calificador_2	449-451	169_QUEST_clinical_caseMIR	SENT1	-	-
18	fractura	fracturar	VMIP3S0	-	-	452-460	169_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
19	?	?	Fit	-	-	460-461	169_QUEST_clinical_caseMIR	SENT1	-	-
20	:	:	Fd	-	-	461-462	169_QUEST_clinical_caseMIR	SENT1	-	-
21	Gestante	gestante	NCFS000	-	-	0-8	169_QUEST_clinical_caseMIR	SENT1	-	-
22	de	de	SPS00	C0332285	atributo	9-11	169_QUEST_clinical_caseMIR	SENT1	-	-
23	36	36		-	-	12-14	169_QUEST_clinical_caseMIR	SENT1	-	-
24	semanas	semana	NCFP000	C0439230	calificador	15-22	169_QUEST_clinical_caseMIR	SENT1	-	-
25	,	,	Fc	-	-	22-23	169_QUEST_clinical_caseMIR	SENT1	-	-
26	prímigesta	prímigesta	NCFS000	-	-	24-34	169_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
27	,	,	Fc	-	-	34-35	169_QUEST_clinical_caseMIR	SENT1	-	-
28	es	ser	VSIP3S0	-	-	36-38	169_QUEST_clinical_caseMIR	SENT1	-	-
29	trasladada	trasladar	VMP00SF	-	-	39-49	169_QUEST_clinical_caseMIR	SENT1	-	-
30	al	al	SP+DA	-	-	50-52	169_QUEST_clinical_caseMIR	SENT1	-	-
31	hospital	hospital	NCMS000	C1510665	medio_ambiente	53-61	169_QUEST_clinical_caseMIR	SENT1	-	-
32	para	para	SPS00	C0521125	calificador	62-66	169_QUEST_clinical_caseMIR	SENT1	-	-
33	valoración	valoración	NCFS000	-	-	67-77	169_QUEST_clinical_caseMIR	SENT1	-	-
34	tras	tras	SPS00	-	-	78-82	169_QUEST_clinical_caseMIR	SENT1	-	-
35	accidente	accidente	NCMS000	C0415499_1	evento_1	83-92	169_QUEST_clinical_caseMIR	SENT1	-	-
36	de	de	SPS00	C0415499_2	evento_2	93-95	169_QUEST_clinical_caseMIR	SENT1	-	-
37	coche	coche	NCMS000	-	-	96-101	169_QUEST_clinical_caseMIR	SENT1	-	-
38	en	en	SPS00	C1720294#C0332285	calificador#atributo	102-104	169_QUEST_clinical_caseMIR	SENT1	-	-
39	cadena	cadena	NCFS000	C3540771#C0337112	metadato_fundacional#objeto_físico	105-111	169_QUEST_clinical_caseMIR	SENT1	-	-
40	en	en	SPS00	C1720294#C0332285	calificador#atributo	112-114	169_QUEST_clinical_caseMIR	SENT1	-	-
41	la	el	DA0FS0	-	-	115-117	169_QUEST_clinical_caseMIR	SENT1	-	-
42	autopista	autopista	NCFS000	C0442647	medio_ambiente	118-127	169_QUEST_clinical_caseMIR	SENT1	-	-
43	,	,	Fc	-	-	127-128	169_QUEST_clinical_caseMIR	SENT1	-	-
44	presentando	presentar	VMG0000	-	-	129-140	169_QUEST_clinical_caseMIR	SENT1	-	-
45	dolor	dolor	NCMS000	C0030193	hallazgo	141-146	169_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
46	cervicodorsal	cervicodorsal	NC00SC0	C0450195	calificador	147-160	169_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
47	.	.	Fp	-	-	160-161	169_QUEST_clinical_caseMIR	SENT1	-	-

1	Durante	durante	SPS00	C1444752#C0347984	atributo	162-169	169_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	170-172	169_QUEST_clinical_caseMIR	SENT2	-	-
3	exploración	exploración	NCFS000	C1280903	procedimiento	173-184	169_QUEST_clinical_caseMIR	SENT2	-	-
4	la	el	DA0FS0	-	-	185-187	169_QUEST_clinical_caseMIR	SENT2	-	-
5	paciente	paciente	NCCS000	C0030705	persona	188-196	169_QUEST_clinical_caseMIR	SENT2	-	-
6	inicia	iniciar	VMIP3S0	-	-	197-203	169_QUEST_clinical_caseMIR	SENT2	-	-
7	dolor	dolor	NCMS000	C0000737_1	hallazgo_1	204-209	169_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
8	abdominal	abdominal	NC00SC0	C0000737_2	hallazgo_2	210-219	169_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
9	intenso	intenso	AQ0MS0	C0205178	calificador	220-227	169_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
10	,	,	Fc	-	-	227-228	169_QUEST_clinical_caseMIR	SENT2	-	-
11	leve	leve	AQ0CS0	C2945599#C0547040#C1282907	calificador	229-233	169_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
12	sangrado	sangrar	VMP00SM	C0426196_1	hallazgo_1	234-242	169_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
13	vaginal	vaginal	AQ0CS0	C0426196_2	hallazgo_2	243-250	169_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
14	oscuro	oscuro	AQ0MS0	C0332582	calificador	251-257	169_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
15	y	y	CC	C1706368	calificador	258-259	169_QUEST_clinical_caseMIR	SENT2	-	-
16	aumento	aumento	NCMS000	C0442805	calificador	260-267	169_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
17	mantenido	mantener	VMP00SM	-	-	268-277	169_QUEST_clinical_caseMIR	SENT2	-	-
18	del	del	SP+DA	-	-	278-281	169_QUEST_clinical_caseMIR	SENT2	-	-
19	tono	tono	NCMS000	-	-	282-286	169_QUEST_clinical_caseMIR	SENT2	-	-
20	uterino	uterino	AQ0MS0	-	-	287-294	169_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
21	.	.	Fp	-	-	294-295	169_QUEST_clinical_caseMIR	SENT2	-	-

